Mode
Text Size
Log in / Sign up

Meta-analysis finds 92% lower RRD odds with prophylaxis in Stickler syndromeThe Inherited Eye Risk Hiding in Plain Sight

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider prophylaxis for RRD in Stickler syndrome, but note high heterogeneity in evidence.

This systematic review and meta-analysis synthesized evidence from 49 studies involving 3492 individuals with genetically or clinically confirmed Stickler syndrome. The analysis compared outcomes between those receiving prophylactic treatment for rhegmatogenous retinal detachment (RRD) and untreated individuals or eyes, though the comparator was not explicitly defined in all included studies.

The pooled prevalence of RRD in individuals with Stickler syndrome was 41.9% (95% CI, 33.78%-50.20%), and 26.1% (95% CI, 19.64%-33.13%) in eyes. Among those receiving prophylaxis, the RRD incidence was 8.7% in individuals (95% CI, 7.09%-10.48%) and 5.1% in eyes (95% CI, 4.02%-6.27%). Prophylaxis was associated with a 92% reduction in the odds of RRD (OR 0.08; 95% CI, 0.04%-0.17%). For surgical repair, the pooled final anatomic success rate was 85.5% (95% CI, 73.13%-94.74%), with combined scleral buckling and vitrectomy achieving 93.6% success (95% CI, 87.26%-97.98%). Safety and tolerability data were not reported.

Key limitations include high statistical heterogeneity (I² = 86.3% for individual prevalence, 82.1% for eye prevalence, 83.9% for surgical outcomes) and moderate to low certainty of evidence. The evidence certainty was moderate for patient-level prophylaxis and surgical outcomes but low for eye-level prophylaxis. The analysis is based on observational data, and the specific prophylactic protocols varied across studies.

For clinical practice, these findings support the potential role of prophylaxis in reducing RRD risk in Stickler syndrome, but the high heterogeneity and observational nature of the evidence preclude definitive conclusions. The surgical success rates, particularly for combined procedures, provide context for managing RRD when it occurs. Decisions should consider individual patient factors and the limitations of the available evidence.

Why the eye is the weak link

Stickler syndrome affects collagen, the protein that gives tissues their shape and strength. That faulty collagen shows up in joints, hearing, and the face. But it hits the eye hardest.

The gel inside the eye, called vitreous, does not form properly. The retina, the thin light-sensing layer at the back of the eye, is tugged on by that weak gel. Tears can form, and fluid can slide behind the retina, peeling it off the wall. That is called rhegmatogenous retinal detachment (caused by a retinal tear).

It is the leading inherited cause of retinal detachment in children. Yet many families do not hear about it until after the first eye emergency.

What the meta-analysis pulled together

Researchers searched six large databases through mid-2025. They kept 49 studies covering 3,492 people with genetically or clinically confirmed Stickler syndrome.

They then pooled the numbers using a standard statistical method called random-effects meta-analysis. That approach assumes each study is a little different and averages their findings while accounting for that variation.

The numbers that matter most

Across 31 studies, about 42% of people with Stickler syndrome had a retinal detachment at some point. Looking at individual eyes, the rate was about 26%. The risk was highest in type 1 Stickler syndrome, the most common form.

Here is the hopeful part. In 12 studies of people who received preventive treatment, only about 9% still developed a detachment. In terms of eyes, only 5% did.

Preventive treatment cut the odds of a detachment by roughly 92% compared with no prevention.

Think of the retina as wallpaper. Stickler syndrome weakens the glue holding it to the wall. Doctors use laser or freezing therapy along the edges of the retina to create tiny scars. Those scars act like nails holding the wallpaper down so a small tear cannot spread into a full peel.

This is a preventive procedure. It does not fix vision. It just keeps the retina from detaching in the first place.

For people who do develop a detachment, surgery still works well. The pooled anatomic success rate was about 86%. The highest success, around 94%, came from a combined approach using both scleral buckling (placing a silicone band around the eye) and vitrectomy (removing the weak gel inside).

Why the catch still matters

The authors were careful to rate the certainty of the evidence. The preventive benefit in patients had moderate-certainty evidence. When counted by eyes, it dropped to low-certainty. The surgical success numbers also had moderate certainty.

Translation. The direction of the finding is clear. Prevention helps. But the exact size of the benefit could shift as stronger, prospective trials report.

What parents and patients can do now

If Stickler syndrome runs in your family, genetic confirmation matters. Many children are diagnosed only after a crisis. A proper eye exam with a retinal specialist, ideally before any symptoms appear, is the first step.

Ask about preventive laser or cryotherapy. This review supports early discussion of that option, especially for type 1 Stickler.

Warning signs to act on fast include sudden floaters, flashes of light, a shadow or curtain in part of the visual field, or any blurred vision after a bump to the head. Those need same-day care.

Honest limits of the evidence

A meta-analysis is only as good as the studies inside it. Many of these were small and observational. Some used different definitions or different follow-up lengths. Heterogeneity, a measure of how much studies disagreed, was high for several outcomes.

That means the pooled numbers are useful estimates, not exact predictions for any one patient. The review authors stated this plainly and called for larger prospective trials comparing prevention methods head-to-head.

The next step is a properly randomized trial. That would assign children with Stickler syndrome to either preventive treatment or close monitoring and then track them for years.

Until those trials exist, the current evidence already points one way. Surveillance and prevention appear to dramatically reduce retinal detachment risk. For families living with Stickler, that is enough reason to have the conversation now.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
TOPIC: Stickler syndrome is an inherited connective tissue disorder with severe ocular manifestations. It is the leading syndromic cause of rhegmatogenous retinal detachment (RRD) particularly in the pediatric population. CLINICAL RELEVANCE: To review the prevalence, prophylactic efficacy, and surgical outcomes of RRD in Stickler syndrome. METHODS: Our protocol was registered on International Prospective Register of Systematic Reviews (PROSPERO) (CRD420251070425). We searched 6 databases and ClinicalTrials.gov from inception to June 2025. Studies reporting RRD-specific data in genetically or clinically confirmed Stickler syndrome were included. The primary outcome was RRD prevalence. Secondary outcomes included prophylactic efficacy and final surgical repair success. Meta-analysis was performed using the random-effects model, with assessment of heterogeneity and publication bias. Risk of bias was assessed using the Joanna Briggs Institute the Newcastle-Ottawa Scale tools. Evidence certainty was assessed using the (Grading of Recommendations Assessment, Development, and Evaluation) framework. RESULTS: A total of 49 studies involving 3492 individuals were included. Thirty-one studies reported the prevalence of RRD in individuals, with a pooled estimate of 41.9% (95% confidence interval [CI], 33.78%-50.20%; I = 86.3%), whereas 23 studies reported prevalence in eyes, with a pooled estimate of 26.1% (95% CI, 19.64%-33.13%; I = 82.1%), with higher rates in type 1 Stickler syndrome. Twelve studies of prophylactically treated individuals showed an RRD incidence of 8.7% (95% CI, 7.09%-10.48%; I = 0.0%), and 15 studies of prophylactically treated eyes showed an incidence of 5.1% (95% CI, 4.02%-6.27%; I = 23.5%). Prophylaxis reduced the odds of RRD by 92% (odds ratio, 0.08; 95% CI, 0.04%-0.17%), with moderate-certainty evidence in patients (I = 76.9%) and low-certainty evidence in eyes (I = 83.5%). Fifteen studies reported surgical outcomes, with a pooled final anatomic success rate of 85.5% (95% CI, 73.13%-94.74%; I = 83.9%), supported by moderate-certainty evidence, and the highest success of 93.6% (95% CI, 87.26%-97.98%; I = 0.0%) was observed in eyes treated with combined scleral buckling and vitrectomy. Overall, most included studies were of acceptable methodologic quality. CONCLUSIONS: Rhegmatogenous retinal detachment is highly prevalent in Stickler syndrome. Prophylaxis significantly reduces this risk, whereas surgery remains effective. These findings support early surveillance and prophylaxis and larger prospective trials comparing prophylactic and surgical techniques. FINANCIAL DISCLOSURE(S): The authors have no proprietary or commercial interest in any materials discussed in this article.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.